Literature DB >> 15304596

A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL.

R Mazzei1, F L Conforti, P L Lanza, T Sprovieri, M R Lupo, O Gallo, A Patitucci, A Magariello, M Caracciolo, A L Gabriele, F Fera, P Valentino, F Bono, G Cenacchi, G Santoro, M Muglia, A Quattrone.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary cerebrovascular disease leading to accumulating neurologic deficits and dementia. CADASIL has been linked to nucleotide substitutions and deletions in the Notch3 gene. All the mutations described until now lead to unpaired cysteine residue in the epidermal growth factor-like repeats. The authors report a family with CADASIL carrying a deletion in the Notch3 gene that did not involve a cysteine residue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304596     DOI: 10.1212/01.wnl.0000133399.37716.84

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Mitochondrial DNA sequence variation and mutation rate in patients with CADASIL.

Authors:  Johanna Annunen-Rasila; Saara Finnilä; Kati Mykkänen; Jukka S Moilanen; Johanna Veijola; Minna Pöyhönen; Matti Viitanen; Hannu Kalimo; Kari Majamaa
Journal:  Neurogenetics       Date:  2006-06-29       Impact factor: 2.660

Review 2.  Clinical and research applications of magnetic resonance imaging in the study of CADASIL.

Authors:  Dorothee Schoemaker; Yakeel T Quiroz; Heirangi Torrico-Teave; Joseph F Arboleda-Velasquez
Journal:  Neurosci Lett       Date:  2019-01-08       Impact factor: 3.046

3.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a genetic cause of cerebral small vessel disease.

Authors:  Jay Chol Choi
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

4.  Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.

Authors:  Anna Bersano; Michela Ranieri; Andrea Ciammola; Claudia Cinnante; Silvia Lanfranconi; Maria Teresa Dotti; Livia Candelise; Cinzaia Baschirotto; Isabella Ghione; Elena Ballabio; Nereo Bresolin; Maria Teresa Bassi
Journal:  Funct Neurol       Date:  2012 Oct-Dec

5.  Clinical presentation of CADASIL in an Italian patient with a rare Gly528Cys exon 10 NOTCH3 gene mutation.

Authors:  M Ragno; G Cacchiò; G M Fabrizi; M Scarcella; F Silvaggio; T Cavallaro; F Taioli; L Trojano
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

6.  Targeted next generation sequencing identifies novel NOTCH3 gene mutations in CADASIL diagnostics patients.

Authors:  Neven Maksemous; Robert A Smith; Larisa M Haupt; Lyn R Griffiths
Journal:  Hum Genomics       Date:  2016-11-24       Impact factor: 4.639

7.  Clinical and imaging features of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and cysteine-sparing NOTCH3 mutations.

Authors:  Hyunjin Kim; Young-Min Lim; Eun-Jae Lee; Yeo Jin Oh; Kwang-Kuk Kim
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

Review 8.  Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome.

Authors:  Vo Van Giau; Eva Bagyinszky; Young Chul Youn; Seong Soo A An; Sang Yun Kim
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

9.  Potential New Cysteine Sparing Mutation in the NOTCH3 Gene in a Patient with Nonfamilial CADASIL-like Disease.

Authors:  Adnan I Qureshi; Muhammad T Khan; Omer Naveed; Muhammad A Saleem
Journal:  J Vasc Interv Neurol       Date:  2017-12

Review 10.  Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL.

Authors:  Elena Muiño; Cristina Gallego-Fabrega; Natalia Cullell; Caty Carrera; Nuria Torres; Jurek Krupinski; Jaume Roquer; Joan Montaner; Israel Fernández-Cadenas
Journal:  Int J Mol Sci       Date:  2017-09-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.